Relationship Between Self-compassion and Treatment Adherence in Schizophrenic Spectrum Disorders

Not Applicable

Withdrawn

• Conditions: Treatment Adherence; Selfcompassion; Schizophrenic Spectrum Disorder

• Registration Number: NCT05566015
• Lead Sponsor: Centre Hospitalier Universitaire, Amiens

Brief Summary

Treatment adherence is defined by the World Health Organisation (WHO) as the extent to which the patient's history of therapeutic drug-taking coincides with the prescribed treatment. In patients suffering from psychiatrical diseases, especially in those who are suffering from schizophrenic spectrum disorders, the quality of treatment adherence has to be improved. Indeed, non adherance to anti-psychotic treatment increases the risk of hospitalization, of substance use, violent behaviour and of functionnal and cognitif impairment. Selfcompassion, which involves being touched by and open to one's own suffering and to heal oneself with kindness and without judgement and self-criticism has never beed studied as a possible factor infuencing treatment adherence.

This study aims to evaluate if a link between selfcompassion and treatment adherence exists in patients suffering from schizophrenic spectrum disorders.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-09-26
• Study First Submitted: 2022-09-30
• Study First Submitted QC: 2022-09-30
• Study First Posted: 2022-10-04
• Status Verified: 2023-07
• Primary Completion: 2023-07-01
• Study Completion: 2023-07-01
• Last Update Submitted: 2023-07-18
• Last Update Posted: 2023-07-20

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• patients diagnosed with schizophrenia spectrum disorder ( ICD 10 and DSM 5 criteria)
• stabilized (PANNS score under 80)
• aged 18 or above
• In case of tutor or curator, agreement of this person is requiered
• psychiatrist who's following the patient agrees with the study

Exclusion Criteria

• underage
• non stabilized patient (PANSS score under 80 )
• patient suffering from toxic psychosis
• difficulties to understand french or cognitive impairment which are making it to difficult to answer the different self-administered questionnaires.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Average level of self compassion	one hour	The level of self compassion will be assessed with the french version of the Self-compassion scale developped and tested by K.Neff.; Average scores for the Self-Compassion Scale are around 3.0 on the 1-5 Likert scale, a score of 1-2.5 indicates low self-compassion, 2.5-3.5 indicates moderate, and 3.5-5.0 is an indication of high self-compassion

Trial Locations

Locations (1)

CHU Amiens; 🇫🇷 Amiens, France